Literature DB >> 12627223

Mechanism of metal activation of human hematopoietic prostaglandin D synthase.

Tsuyoshi Inoue1, Daisuke Irikura, Nobuo Okazaki, Shigehiro Kinugasa, Hiroyoshi Matsumura, Nobuko Uodome, Masaki Yamamoto, Takashi Kumasaka, Masashi Miyano, Yasushi Kai, Yoshihiro Urade.   

Abstract

Here we report the crystal structures of human hematopoietic prostaglandin (PG) D synthase bound to glutathione (GSH) and Ca2+ or Mg2+. Using GSH as a cofactor, prostaglandin D synthase catalyzes the isomerization of PGH2 to PGD2, a mediator for allergy response. The enzyme is a homodimer, and Ca2+ or Mg2+ increases its activity to approximately 150% of the basal level, with half maximum effective concentrations of 400 microM for Ca2+ and 50 microM for Mg2+. In the Mg2+-bound form, the ion is octahedrally coordinated by six water molecules at the dimer interface. The water molecules are surrounded by pairs of Asp93, Asp96 and Asp97 from each subunit. Ca(2+) is coordinated by five water molecules and an Asp96 from one subunit. The Asp96 residue in the Ca2+-bound form makes hydrogen bonds with two guanidium nitrogen atoms of Arg14 in the GSH-binding pocket. Mg2+ alters the coordinating water structure and reduces one hydrogen bond between Asp96 and Arg14, thereby changing the interaction between Arg14 and GSH. This effect explains a four-fold reduction in the K(m) of the enzyme for GSH. The structure provides insights into how Ca2+ or Mg2+ binding activates human hematopoietic PGD synthase.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12627223     DOI: 10.1038/nsb907

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN: 1072-8368


  21 in total

Review 1.  Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis.

Authors:  William L Smith; Yoshihiro Urade; Per-Johan Jakobsson
Journal:  Chem Rev       Date:  2011-09-27       Impact factor: 60.622

2.  Determination of neuroinflammatory biomarkers in autistic and neurotypical Saudi children.

Authors:  Najat O Hamed; Mohamed A Osman; Abdalla O Elkhawad; Geir Bjørklund; Hanan Qasem; Naima Zayed; Afaf El-Ansary
Journal:  Metab Brain Dis       Date:  2019-05-30       Impact factor: 3.584

3.  Discovery of an Oral Potent Selective Inhibitor of Hematopoietic Prostaglandin D Synthase (HPGDS).

Authors:  Chris P Carron; John I Trujillo; Kirk L Olson; Wei Huang; Bruce C Hamper; Tom Dice; Bradley E Neal; Matthew J Pelc; Jacqueline E Day; Douglas C Rohrer; James R Kiefer; Joseph B Moon; Barbara A Schweitzer; Tanisha D Blake; Steve R Turner; Rhonda Woerndle; Brenda L Case; Christine P Bono; Vickie M Dilworth; Christie L Funckes-Shippy; Becky L Hood; Gina M Jerome; Christine M Kornmeier; Melissa R Radabaugh; Melanie L Williams; Michael S Davies; Craig D Wegner; Dean J Welsch; William M Abraham; Chad J Warren; Martin E Dowty; Fengmei Hua; Anup Zutshi; Jerry Z Yang; Atli Thorarensen
Journal:  ACS Med Chem Lett       Date:  2010-02-02       Impact factor: 4.345

4.  Hematopoietic prostaglandin D synthase (HPGDS): a high stability, Val187Ile isoenzyme common among African Americans and its relationship to risk for colorectal cancer.

Authors:  Brigette L Tippin; A Joan Levine; Alicia M Materi; Wen-Liang Song; Temitope O Keku; Julie E Goodman; Leah B Sansbury; Sudipto Das; Aihua Dai; Alan M Kwong; Amy M Lin; John M Lin; Jae Man Park; Ruth E Patterson; Rowan T Chlebowski; R Michael Garavito; Tsuyoshi Inoue; Wonhwa Cho; John A Lawson; Shiv Kapoor; Laurence N Kolonel; Loïc Le Marchand; Robert W Haile; Robert S Sandler; Henry J Lin
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-07-28       Impact factor: 3.072

5.  Structure of monomeric Na-GST-3, a glutathione S-transferase from the major human hookworm parasite Necator americanus.

Authors:  Alan Kelleher; Bin Zhan; Oluwatoyin A Asojo
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-07-27

6.  Structural and dynamic insights into substrate binding and catalysis of human lipocalin prostaglandin D synthase.

Authors:  Sing Mei Lim; Dan Chen; Hsiangling Teo; Annette Roos; Anna Elisabet Jansson; Tomas Nyman; Lionel Trésaugues; Konstantin Pervushin; Pär Nordlund
Journal:  J Lipid Res       Date:  2013-03-22       Impact factor: 5.922

7.  Inhibition of prostaglandin D synthase suppresses muscular necrosis.

Authors:  Ikuko Mohri; Kosuke Aritake; Hidetoshi Taniguchi; Yo Sato; Shinya Kamauchi; Nanae Nagata; Toshihiko Maruyama; Masako Taniike; Yoshihiro Urade
Journal:  Am J Pathol       Date:  2009-04-09       Impact factor: 4.307

8.  Comparison of PGH2 binding site in prostaglandin synthases.

Authors:  Padmapriya Paragi-Vedanthi; Mukesh Doble
Journal:  BMC Bioinformatics       Date:  2010-01-18       Impact factor: 3.169

9.  Biochemical, functional, and pharmacological characterization of AT-56, an orally active and selective inhibitor of lipocalin-type prostaglandin D synthase.

Authors:  Daisuke Irikura; Kosuke Aritake; Nanae Nagata; Toshihiko Maruyama; Shigeru Shimamoto; Yoshihiro Urade
Journal:  J Biol Chem       Date:  2009-01-08       Impact factor: 5.157

Review 10.  The enzymology of the human prostanoid pathway.

Authors:  Roger Gregory Biringer
Journal:  Mol Biol Rep       Date:  2020-05-19       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.